Advertisement
PCH vs PCRX
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PCH is a Hold and PCRX is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
PCH’s FA Score shows that 0 FA rating(s) are green whilePCRX’s FA Score has 0 green FA rating(s).
- PCH’s FA Score: 0 green, 5 red.
- PCRX’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
PCH’s TA Score shows that 4 TA indicator(s) are bullish while PCRX’s TA Score has 4 bullish TA indicator(s).
- PCH’s TA Score: 4 bullish, 5 bearish.
- PCRX’s TA Score: 4 bullish, 5 bearish.
Price Growth
PCH (@Real Estate Investment Trusts) experienced а -6.17% price change this week, while PCRX (@Pharmaceuticals: Other) price change was -1.93% for the same time period.
The average weekly price growth across all stocks in the @Real Estate Investment Trusts industry was -1.12%. For the same industry, the average monthly price growth was +1.67%, and the average quarterly price growth was +0.79%.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +80.51%. For the same industry, the average monthly price growth was +15.81%, and the average quarterly price growth was +291.07%.
Reported Earning Dates
PCH is expected to report earnings on Jul 28, 2025.
PCRX is expected to report earnings on Aug 05, 2025.
Industries' Descriptions
@Real Estate Investment Trusts (-1.12% weekly)A real estate investment trust (REIT) is a company any that owns, and in most cases, operates, income-producing real estate – ranging from office and apartment buildings to warehouses, hospitals, shopping centers, hotels and timberlands. Some REITs are involved in financing real estate. Equity REITs invest in and own properties, while mortgage REITs own and invest in property mortgages. REITs are required by law to pay out at least 90% of their annual taxable income (excluding capital gains) to shareholders in the form of dividends. Some REITs could be more cyclical than others; for example, when an economy is undergoing a recession, hotel REITs could be more vulnerable, compared to say healthcare REIT given that healthcare needs are less likely to depend on economic cycles. American Tower Corporation, Prologis, Inc. and Crown Castle International Corp are some of the biggest REIT companies in the U.S.
@Pharmaceuticals: Other (+80.51% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
| PCH | PCRX | PCH / PCRX | |
| Capitalization | 3.74B | 1.36B | 276% |
| EBITDA | 207M | 155M | 134% |
| Gain YTD | -1.846 | 29.459 | -6% |
| P/E Ratio | 60.61 | 32.74 | 185% |
| Revenue | 1.02B | 675M | 152% |
| Total Cash | 230M | 279M | 82% |
| Total Debt | 1.03B | 586M | 176% |
PCH | PCRX | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 12 | 71 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 62 Fair valued | 54 Fair valued | |
PROFIT vs RISK RATING 1..100 | 48 | 100 | |
SMR RATING 1..100 | 87 | 93 | |
PRICE GROWTH RATING 1..100 | 60 | 52 | |
P/E GROWTH RATING 1..100 | 67 | 100 | |
SEASONALITY SCORE 1..100 | 50 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
PCRX's Valuation (54) in the Pharmaceuticals Other industry is in the same range as PCH (62) in the Real Estate Investment Trusts industry. This means that PCRX’s stock grew similarly to PCH’s over the last 12 months.
PCH's Profit vs Risk Rating (48) in the Real Estate Investment Trusts industry is somewhat better than the same rating for PCRX (100) in the Pharmaceuticals Other industry. This means that PCH’s stock grew somewhat faster than PCRX’s over the last 12 months.
PCH's SMR Rating (87) in the Real Estate Investment Trusts industry is in the same range as PCRX (93) in the Pharmaceuticals Other industry. This means that PCH’s stock grew similarly to PCRX’s over the last 12 months.
PCRX's Price Growth Rating (52) in the Pharmaceuticals Other industry is in the same range as PCH (60) in the Real Estate Investment Trusts industry. This means that PCRX’s stock grew similarly to PCH’s over the last 12 months.
PCH's P/E Growth Rating (67) in the Real Estate Investment Trusts industry is somewhat better than the same rating for PCRX (100) in the Pharmaceuticals Other industry. This means that PCH’s stock grew somewhat faster than PCRX’s over the last 12 months.
| PCH | PCRX | |
|---|---|---|
| RSI ODDS (%) | N/A | N/A |
| Stochastic ODDS (%) | 2 days ago 71% | 2 days ago 74% |
| Momentum ODDS (%) | 2 days ago 66% | 2 days ago 79% |
| MACD ODDS (%) | N/A | 2 days ago 74% |
| TrendWeek ODDS (%) | 2 days ago 58% | 2 days ago 78% |
| TrendMonth ODDS (%) | 2 days ago 51% | 2 days ago 80% |
| Advances ODDS (%) | 8 days ago 61% | 14 days ago 71% |
| Declines ODDS (%) | 2 days ago 62% | 7 days ago 78% |
| BollingerBands ODDS (%) | 2 days ago 78% | 2 days ago 78% |
| Aroon ODDS (%) | 2 days ago 59% | 2 days ago 72% |
Advertisement
PCH and
Correlation & Price change
A.I.dvisor indicates that over the last year, PCH has been closely correlated with WY. These tickers have moved in lockstep 84% of the time. This A.I.-generated data suggests there is a high statistical probability that if PCH jumps, then WY could also see price increases.
PCRX and
Correlation & Price change
A.I.dvisor tells us that PCRX and ELAN have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PCRX and ELAN's prices will move in lockstep.
| Ticker / NAME | Correlation To PCRX | 1D Price Change % | ||
|---|---|---|---|---|
| PCRX | 100% | +0.21% | ||
| ELAN - PCRX | 32% Poorly correlated | -2.72% | ||
| TEVA - PCRX | 28% Poorly correlated | -3.49% | ||
| ACET - PCRX | 27% Poorly correlated | -6.10% | ||
| SNDL - PCRX | 26% Poorly correlated | -3.76% | ||
| NBIX - PCRX | 25% Poorly correlated | -0.10% | ||
More | ||||